Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miyuki Azuma

Showing results (131-140 of 156) with videos related to

Pageof 16
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|March 8, 2005
Role of the programmed death-1 pathway in regulation of alloimmune responses in vivoSigrid E Sandner, Michael R Clarkson, Alan D Salama, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 7, 2004
B7-DC regulates asthmatic response by an IFN-gamma-dependent mechanismKoichiro Matsumoto, Hiromasa Inoue, Takako Nakano, et al.
Blood|March 10, 2011
Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell exhaustion phenotype in mice with disseminated acute myelogenous leukemiaQing Zhou, Meghan E Munger, Rachelle G Veenstra, et al.
European Journal of Immunology|January 30, 2015
Differential control of CD4(+) T-cell subsets by the PD-1/PD-L1 axis in a mouse model of allergic asthmaJaclyn W McAlees, Stephane Lajoie, Krista Dienger, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 8, 2003
Blockade of B7-H1 suppresses the development of chronic intestinal inflammationTakanori Kanai, Teruji Totsuka, Koji Uraushihara, et al.
Nature Communications|June 6, 2023
Evaluation of therapeutic PD-1 antibodies by an advanced single-molecule imaging system detecting human PD-1 microclustersWataru Nishi, Ei Wakamatsu, Hiroaki Machiyama, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2005
Clinical significance of programmed death-1 ligand-1 and programmed death-1 ligand-2 expression in human esophageal cancerYuichiro Ohigashi, Masayuki Sho, Yukishige Yamada, et al.
The Journal of Experimental Medicine|July 9, 2003
The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) miceMohammed Javeed I Ansari, Alan D Salama, Tanuja Chitnis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 22, 2007
Peripheral tolerance and the qualitative characteristics of autoreactive T cell clones in primary biliary cirrhosisAkira Kawano, Shinji Shimoda, Takashi Kamihira, et al.
Clinical Immunology (Orlando, Fla.)|July 14, 2007
Mechanisms of PDL1-mediated regulation of autoimmune diabetesIndira Guleria, Melanie Gubbels Bupp, Shirine Dada, et al.
Pageof 16

Showing results (131-140 of 156) with videos related to

Sort By:
Pageof 16
Journal of Immunology (Baltimore, Md. : 1950)|March 8, 2005
Role of the programmed death-1 pathway in regulation of alloimmune responses in vivoSigrid E Sandner, Michael R Clarkson, Alan D Salama, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 7, 2004
B7-DC regulates asthmatic response by an IFN-gamma-dependent mechanismKoichiro Matsumoto, Hiromasa Inoue, Takako Nakano, et al.
Blood|March 10, 2011
Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell exhaustion phenotype in mice with disseminated acute myelogenous leukemiaQing Zhou, Meghan E Munger, Rachelle G Veenstra, et al.
European Journal of Immunology|January 30, 2015
Differential control of CD4(+) T-cell subsets by the PD-1/PD-L1 axis in a mouse model of allergic asthmaJaclyn W McAlees, Stephane Lajoie, Krista Dienger, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 8, 2003
Blockade of B7-H1 suppresses the development of chronic intestinal inflammationTakanori Kanai, Teruji Totsuka, Koji Uraushihara, et al.
Nature Communications|June 6, 2023
Evaluation of therapeutic PD-1 antibodies by an advanced single-molecule imaging system detecting human PD-1 microclustersWataru Nishi, Ei Wakamatsu, Hiroaki Machiyama, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2005
Clinical significance of programmed death-1 ligand-1 and programmed death-1 ligand-2 expression in human esophageal cancerYuichiro Ohigashi, Masayuki Sho, Yukishige Yamada, et al.
The Journal of Experimental Medicine|July 9, 2003
The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) miceMohammed Javeed I Ansari, Alan D Salama, Tanuja Chitnis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 22, 2007
Peripheral tolerance and the qualitative characteristics of autoreactive T cell clones in primary biliary cirrhosisAkira Kawano, Shinji Shimoda, Takashi Kamihira, et al.
Clinical Immunology (Orlando, Fla.)|July 14, 2007
Mechanisms of PDL1-mediated regulation of autoimmune diabetesIndira Guleria, Melanie Gubbels Bupp, Shirine Dada, et al.
Pageof 16